Single blood thinner after shielded stent for brain aneurysm
Part of Brain & nervous system, Heart & circulation clinical trials.
This study is testing whether using only one blood-thinning medication (single antiplatelet therapy) after placing a special stent (Pipeline Flex with Shield) is safe and effective for treating unruptured brain aneurysms. It is for people who have already been on two blood thinners for a few days before the stent placement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have an unruptured brain aneurysm (one that hasn't bled) and are getting a Pipeline Flex with Shield stent.
- The main artery in your brain that the stent will go into is at least 2.5 mm wide, not heavily calcified, and not very curved.
- You must have taken two blood-thinning medications (dual antiplatelet therapy) for at least 3 days before the stent procedure.
- Your aneurysm shape is not irregular (not fusiform, blister-like, or dissecting).
- You have not had a stroke or aneurysm rupture in the last 3 months.
- You do not have a known allergy to clopidogrel or heparin, and your platelet count is not too low.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if placing a drug-coated stent in a narrowed artery in the neck, followed by a shorter course of two blood thinners, can better prevent another stroke in people with symptomatic vertebral artery stenosis.
This trial is collecting information from people who already received a specific type of stent (Lattice Flow-Diverting Dense-Mesh Stent) to treat an unruptured brain aneurysm. The goal is to learn how well the stent works and improve future treatments.
This study compares two combinations of blood thinners to see which works better for preventing clots after a stent procedure to treat an unruptured brain aneurysm. It is for people who have a specific gene test result that shows they process medicines normally.
This trial tests a treatment called Pipeline Embolization (a thin tube placed in the artery) to fix brain aneurysms that haven't ruptured. It might help stop the aneurysm from growing or bursting.
This trial studies the best way to use blood-thinning medicines after placing a NeoVas™ dissolving stent in the heart. It may help prevent dangerous blood clots in the stent while reducing side effects like bleeding.
This trial tests a flow-diverting stent for treating certain brain aneurysms located in distal parts of the brain's arteries. It’s for people who have already received this stent and are between 18 and 80 years old.
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.